Effient and Hyperlipidaemia - a phase IV clinical study of FDA data

Summary:

Hyperlipidaemia is reported as a side effect among people who take Effient (prasugrel hydrochloride), especially for people who are male, 50-59 old, also take Brilinta, and have Hyperkalemia.

The phase IV clinical study analyzes which people have Hyperlipidaemia when taking Effient. It is created by eHealthMe based on reports of 9,155 people who have side effects when taking Effient from the FDA, and is updated regularly.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,428 drugs and 1,407 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

On Jul, 07, 2026

9,155 people reported to have side effects when taking Effient.
Among them, 13 people (0.14%) have Hyperlipidaemia.

Among these 13 people:

What is the gender of people who have Hyperlipidaemia when taking Effient? *

female: 50 %
male: 50 %

What is the age of people who have Hyperlipidaemia when taking Effient? *

What are other drugs people take besides Effient? *

What are other side effects people have besides Hyperlipidaemia? *

High Blood Pressure: 7 people, 53.85%
Stress And Anxiety: 4 people, 30.77%
Diabetes: 4 people, 30.77%
Heart Attack: 4 people, 30.77%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 23.08%
Rashes (redness): 3 people, 23.08%
Depression: 3 people, 23.08%
Diarrhea: 3 people, 23.08%
Dyspnea (difficult or laboured breathing): 3 people, 23.08%
Hypokinesia (decreased bodily movement): 3 people, 23.08%

What are the existing conditions these people have? *

Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 2 people, 15.38%
Renal Disorder (kidney disease): 2 people, 15.38%
Percutaneous Coronary Intervention: 2 people, 15.38%
Acute Kidney Failure: 2 people, 15.38%
Chest Pain: 2 people, 15.38%
Chronic Kidney Disease: 2 people, 15.38%
Hyperkalemia (damage to or disease of the kidney): 2 people, 15.38%
Heart Attack: 1 person, 7.69%
Bipolar Disorder (mood disorder): 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Effient and have Hyperlipidaemia?

- Check whether Hyperlipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effient:

Effient (9,482 reports)

Hyperlipidaemia treatments and more:

Hyperlipidaemia (86,394 reports)

Browse all side effects of Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,428 drugs)

Browse all the conditions that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,407 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prasugrel hydrochloride (the active ingredients of Effient) and Effient (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.